Ambu A/S (AMBFF)
12.75
0.00 (0.00%)
USD |
OTCM |
Dec 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.399B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -35.61% |
| Valuation | |
| PE Ratio | 38.00 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.801 |
| Price to Book Value | 3.578 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.0631 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0906 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 89.66% |
Profile
| Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark. |
| URL | http://www.ambu.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Feb. 04, 2026 |
| Last Earnings Release | Nov. 05, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 05, 2025 |
Ratings
Profile
| Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark. |
| URL | http://www.ambu.com |
| Investor Relations URL | N/A |
| HQ State/Province | Capital Region |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Feb. 04, 2026 |
| Last Earnings Release | Nov. 05, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 05, 2025 |